Pharma Surveyor
Pharma Surveyor is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Pharma Surveyor.
Pharma Surveyor is a company.
Key people at Pharma Surveyor.
Surveyor Health is a healthcare technology company operating as an R&D lab focused on developing and scientifically evaluating novel AI technology for medication management.[1] It builds SurveyorAI, a proprietary probabilistic AI platform that optimizes complex drug regimens, reduces care costs by 19.3% (p < 0.001), and supports programs like Medication Reconciliation, Therapy Management, and Transitions of Care.[2][1] Serving health plans, hospitals, managed care organizations, risk-bearing entities, and high-risk patients across commercial, Medicare, and Medicaid lines, it solves medication mismanagement—linked to over 200,000 annual deaths—by integrating with payer claims and EHR data for targeted interventions, stratification, and pharmacist-led recommendations.[1][2] The company has piloted with top managed care, accountable care, and Medicaid plans, demonstrating reliable, non-hallucinating AI outcomes in high-complexity cohorts.[1]
Surveyor Health was founded by Linda and Erick, who pivoted from government defense projects after Linda's mother faced opioid medication issues, revealing parallels between their prior tech and drug regimen optimization.[1] Before Surveyor Health, as principals of Synsyta (2000-2006), they led a consortium of 8 companies and academics on advanced AI projects for GSA, DARPA, DOD, and intelligence agencies, involving symbolic AI, neuromorphic architectures, machine learning, ontologies, and grid computing.[1] Realizing protocol stack creation mirrored medication regimens—and aware of mismanagement's deadly toll—they shifted focus to healthcare, with SurveyorAI becoming their passion project, evolving through years of pilots at leading healthcare organizations.[1]
Surveyor Health rides the AI-in-healthcare wave, particularly probabilistic AI for population health amid rising medication complexity, polypharmacy risks, and value-based care demands.[1][2] Timing aligns with post-pandemic emphasis on cost control, telemedicine, and care coordination, where mismanaged regimens exacerbate 200,000+ deaths yearly and strain systems.[1] Market forces like EHR interoperability mandates, payer risk stratification needs, and pharmacist empowerment favor it, as traditional tools falter on high-complexity patients.[2] By influencing optimized regimens at scale, it shapes the ecosystem toward AI-augmented clinical decisions, reducing readmissions and costs for ACOs and health plans.[1][2]
Surveyor Health is poised for expansion as AI medication platforms gain traction in risk-bearing models, with next steps likely including broader EHR integrations, global pilots, and partnerships with pharma for regimen-aligned therapies. Trends like multimodal AI, real-world evidence mandates, and chronic disease surges will amplify its edge, potentially evolving it into a standard for comprehensive medication management. This R&D lab's defense-honed tech, sparked by a personal crisis, positions it to transform healthcare's deadliest inefficiency into a scalable win.
Key people at Pharma Surveyor.
